Will Gilead, the acquirer, be Gilead, the acquired? Not likely
June 08, 2020 at 17:13 PM EDT
In 2012, Gilead CEO Dan O'Day replaced AstraZeneca CEO (and onetime Genentech CEO) Pascal Soriot as chief operating officer of Roche Pharma.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|